MPM Asset Management’s MacroGenics MGNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-3,168
Closed -$86K 9
2016
Q2
$86K Hold
3,168
0.03% 13
2016
Q1
$59K Hold
3,168
0.02% 15
2015
Q4
$98K Hold
3,168
0.02% 15
2015
Q3
$68K Hold
3,168
0.01% 16
2015
Q2
$120K Hold
3,168
0.02% 15
2015
Q1
$99K Hold
3,168
0.02% 15
2014
Q4
$111K Hold
3,168
0.02% 15
2014
Q3
$66K Hold
3,168
0.02% 13
2014
Q2
$69K Sell
3,168
-1,777,787
-100% -$37.4M 0.02% 14
2014
Q1
$49.6M Hold
1,780,955
20.98% 3
2013
Q4
$48.9M Buy
+1,780,955
New +$46.6M 15.78% 4

Other funds holding MGNX

MPM Asset Management's MGNX Position: Q3 2016 in Review

MPM Asset Management sold out of MacroGenics (MGNX) in Q3 2016, closing a stake of 3,168 shares — an estimated $86K sold.

MPM Asset Management first reported a position in MGNX in Q4 2013 and held it in 11 quarters. The position peaked at $49.6M in Q1 2014. 133 funds tracked by Wall St. Rank hold MGNX as of Q3 2016.

  • MPM Asset Management reported no remaining MacroGenics position as of Q3 2016 after selling out during the quarter.
  • MPM Asset Management sold 3,168 MacroGenics shares in Q3 2016, an estimated $86K.
  • MPM Asset Management first reported a position in MacroGenics in Q4 2013 and held it in 11 quarters.
  • MPM Asset Management's MacroGenics position peaked at $49.6M in Q1 2014.
  • 133 funds tracked by Wall St. Rank held MacroGenics as of Q3 2016.

Based on MPM Asset Management's 13F filing for Q3 2016, filed 10 Nov 2016.